Dambkowski Carl's Form 4 filing
Oruka Therapeutics, Inc. (ORKA) · filed Jun 12, 2026
- Accession no.
- 0000907654-26-000054
- Filed
- Jun 12, 2026
- Trade date
- Jun 11-12, 2026
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $2.45M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Dambkowski CarlCIK 0001983476 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 11, 2026 | Common Stock | SSaleDisposed | −22,417 | $70.13 | −$1,572,104.21 | 51,326 | Direct | |
| Jun 12, 2026 | Common Stock | SSaleDisposed | −12,583 | $70.11 | −$882,194.13 | 38,743 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.